Chromatin-modifying agents permit human hematopoietic stem cells to undergo multiple cell divisions while retaining their repopulating potential
The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
Human hematopoietic stem cells (HSCs) exposed to cytokines in vitro rapidly divide and lose their characteristic functional properties presumably due to the alteration of a genetic program that determines the properties of an HSC. We have attempted to reverse the silencing of this HSC genetic program by the sequential treatment of human cord blood CD34+ cells with the chromatin-modifying agents, 5-aza-2′-deoxycytidine (5azaD) and trichostatin A (TSA). We determined that all CD34+CD90+ cells treated with 5azaD/TSA and cytokines after 9 days of incubation divide, but to a lesser degree than cells exposed to only cytokines. When CD34+CD90+ cells that have undergone extensive number of cell divisions (5-10) in the presence of cytokines alone were transplanted into immunodeficient mice, donor cell chimerism was not detectable. By contrast, 5azaD/TSA-treated cells that have undergone similar numbers of cell divisions retained their marrow repopulating potential. The expression of several genes and their products previously implicated in HSC self-renewal were up-regulated in the cells treated with 5azaD/TSA as compared to cells exposed to cytokines alone. These data indicate that HSC treated with chromatin-modifying agents are capable of undergoing repeated cell divisions in vitro while retaining their marrow-repopulating potential.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The DNA hypomethylating drug decitabine maintains normal hematopoietic stem cell (HSC) self-renewal but induces terminal differentiation in acute myeloid leukemia (AML) cells.”
From CpG methylation patterns and decitabine treatment response in acute myeloid leukemia cells and normal hematopoietic precursors (2012) · cites this paper as [9]
In the citing paper
“In contrast, in normal HSC which do not express high levels of lineage-specifying TF, DNMT1 depletion prevents stem cell gene repression by differentiation stimuli, thereby maintaining stem cell phenotype (6–15).”
From CpG methylation patterns and decitabine treatment response in acute myeloid leukemia cells and normal hematopoietic precursors (2012) · cites this paper as [9]
Citations
Cites
Heid, C. A., Stevens, J., Livak, K. J., & Williams, P. M. (1996) · Genome Research · doi:10.1101/gr.6.10.986 · Cited by 6,174
Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells.
Park, I.-K., Qian, D., Kiel, M., Becker, M. W., Pihalja, M., Weissman, I. L., Morrison, S. J., & Clarke, M. F. (2003) · Nature · doi:10.1038/nature01587 · Cited by 1,871
Differentiation and proliferation of hematopoietic stem cells
Ogawa, M. (1993) · Blood · doi:10.1182/blood.v81.11.2844.2844 · Cited by 1,383
Hematopoietic Stem Cell Quiescence Maintained by p21 cip1/waf1
Cheng, T., Rodrigues, N., Shen, H., Yang, Y.-G., Dombkowski, D., Sykes, M., & Scadden, D. T. (2000) · Science · doi:10.1126/science.287.5459.1804 · Cited by 1,339
Pevny, L., Simon, M. C., Robertson, E., Klein, W. H., Tsai, S.-F., D'Agati, V., Orkin, S. H., & Costantini, F. (1991) · Nature · doi:10.1038/349257a0 · Cited by 1,308
An early haematopoietic defect in mice lacking the transcription factor GATA-2
Tsai, F.-Y., Keller, G., Kuo, F. C., Weiss, M., Chen, J., Rosenblatt, M., Alt, F. W., & Orkin, S. H. (1994) · Nature · doi:10.1038/371221a0 · Cited by 1,237
Metcalf, D. (1989) · Nature · doi:10.1038/339027a0 · Cited by 1,023
In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells
Cheshier, S. H., Morrison, S. J., Liao, X., & Weissman, I. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3120 · Cited by 858
c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation
Wilson, A., Murphy, M. J., Oskarsson, T., Kaloulis, K., Bettess, M. D., Oser, G. M., Pasche, A.-C., Knabenhans, C., MacDonald, H. R., & Trumpp, A. (2004) · Genes & Development · doi:10.1101/gad.313104 · Cited by 823
Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1
Iwama, A., Oguro, H., Negishi, M., Kato, Y., Morita, Y., Tsukui, H., Ema, H., Kamijo, T., Katoh-Fukui, Y., Koseki, H., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.11.004 · Cited by 515
Cited by
Current Perspectives on “Off-The-Shelf” Allogeneic NK and CAR-NK Cell Therapies
Heipertz, E. L., Zynda, E. R., Stav-Noraas, T. E., Hungler, A. D., Boucher, S. E., Kaur, N., & Vemuri, M. C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.732135 · Cited by 211
“Alternatively, CD34 hematopoietic stem cells can be isolated from UCB and differentiated to NK cells (19, 29).”
BackgroundHematopoietic stem cell expansion: challenges and opportunities
Walasek, M. A., van Os, R., & de Haan, G. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06549.x · Cited by 221
Commonly used mesenchymal stem cell markers and tracking labels: Limitations and challenges.
Lin, C., Xin, Z., Dai, J., & Lue, T. F. (2013) · PubMed · doi:10.14670/hh-28.1109 · Cited by 210
“Although varied between species, CD90 expression has been identified in endothelial cells (both vascular and lymphatic), hematopoietic stem cells, lymphocytes, fibroblasts, and neurons (Craig et al., 1993; Saalbach et al., 1999; Rege and Hagood, 2006; Araki et al., 2007; Jurisic et al., 2010).”
Macrophage polarization in response to epigenetic modifiers during infection and inflammation
Patel, U., Rajasingh, S., Samanta, S., Cao, T., Dawn, B., & Rajasingh, J. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2016.08.006 · Cited by 215
“Studies have shown that DNA methylation and histone deacetylation dictate the fate of a cell and its gene expression [88,100].”
BackgroundEpigenetic reprogramming induces the expansion of cord blood stem cells
Chaurasia, P., Gajzer, D. C., Schaniel, C., D’Souza, S., & Hoffman, R. (2014) · Journal of Clinical Investigation · doi:10.1172/jci70313 · Cited by 155
“…mice were sublethally irradiated with 300 cGy 4 hours prior to the infusion of PCs (2 × 10 5 ), and CD34 + cells reisolated after a week of culture under control conditions or cultures containing VPA in the presence or absence of cytokines were injected into NSG mice via the tail vein (17, 26, 27).”
InfluentialSelf-citation
Metadata
- Authors
- Araki, H., Yoshinaga, K., Boccuni, P., Zhao, Y., Hoffman, R., & Mahmud, N.
- Affiliations
- University of Illinois Chicago (US)
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2006-12-21
- Volume
- 109
- Issue
- 8
- Pages
- 3570-3578
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2072808238
- Cited by
- 98
- References
- 62
- Citations by year
- 2025: 3 · 2024: 2 · 2023: 2 · 2022: 1 · 2021: 3 · 2020: 6 · 2019: 4 · 2018: 3 · 2017: 4 · 2016: 7 · 2015: 7 · 2014: 6 · 2013: 6 · 2012: 12
- FWCI
- 2.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- hematopoietic stem cells, decitabine, trichostatin A, umbilical cord blood, self-renewal, gene silencing, gene upregulation, donor chimerism
- MeSH terms
- Decitabine, Animals, Azacitidine, Cell Division, Cells, Cultured, Chromatin, Enzyme Inhibitors, Hematopoietic Stem Cells, Humans, Hydroxamic Acids, Time Factors, Transplantation, Heterologous, Up-Regulation, Cytokines, Mice, SCID, Mice, Inbred NOD, Hematopoietic Stem Cell Transplantation, Thy-1 Antigens, Antigens, CD34, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chromatin-modifying agents permit human hematopoietic stem cells to undergo multiple cell divisions while retaining their repopulating potential. https://app.cochat.ai/papers/10.1182/blood-2006-07-035287
- The paper
- Araki, H., Yoshinaga, K., Boccuni, P., Zhao, Y., Hoffman, R., & Mahmud, N. (2007). Chromatin-modifying agents permit human hematopoietic stem cells to undergo multiple cell divisions while retaining their repopulating potential. Blood. https://doi.org/10.1182/blood-2006-07-035287
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.